Literature DB >> 15501592

Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.

A T Nies1, G Jedlitschky, J König, C Herold-Mende, H H Steiner, H-P Schmitt, D Keppler.   

Abstract

Multidrug resistance proteins (MRPs, symbol ABCC) are membrane glycoproteins that mediate the ATP-dependent export of organic anions, including cytotoxic and antiviral drugs, from cells. To identify MRP family members possibly involved in the intrinsic resistance of human brain to cytotoxic and antiviral drugs, we analyzed the expression and localization of MRP1-MRP6 in rapidly frozen perilesional samples of several regions of adult human brain obtained during neurosurgery. Quantitative polymerase chain reaction analysis showed expression of MRP1, MRP2, MRP3, MRP4, and MRP5 mRNA, whereas MRP6 mRNA was below detectability. However, immunofluorescence microscopy of cryosections from human brain showed no reactivity for the MRP2 or MRP3 proteins. The proteins MRP1, MRP4, and MRP5 were clearly localized by confocal laser scanning microscopy to the luminal side of brain capillary endothelial cells. The MRP4 and MRP5 proteins were also detected in astrocytes of the subcortical white matter. Notably, MRP5 protein was present in pyramidal neurons. MRP proteins may, thus, contribute to the cellular efflux of endogenous anionic glutathione or glucuronate conjugates (substrates for MRP1), cyclic nucleotides (substrates for MRP4 and MRP5), or glutathione (co-substrate for MRP1 and MRP4); in addition, they may play an important role in the resistance of the brain to several cytotoxic and antiviral drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501592     DOI: 10.1016/j.neuroscience.2004.07.051

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  106 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 2.  Apicobasal polarity of brain endothelial cells.

Authors:  Thomas Worzfeld; Markus Schwaninger
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-06       Impact factor: 6.200

3.  Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymes.

Authors:  Jeffrey C Sivils; Iven Gonzalez; Lisa J Bain
Journal:  Gen Comp Endocrinol       Date:  2010-02-21       Impact factor: 2.822

4.  Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.

Authors:  Brian T Hawkins; Scott M Ocheltree; Kristi M Norwood; Richard D Egleton
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

Review 5.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 6.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Expression of multidrug resistance proteins (Mrps) in astrocytes of the mouse brain: a single cell RT-PCR study.

Authors:  Johannes Hirrlinger; Heinz Moeller; Frank Kirchhoff; Ralf Dringen
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

8.  Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers.

Authors:  David J Brayden; Joanna Griffin
Journal:  Vet Res Commun       Date:  2007-06-20       Impact factor: 2.459

Review 9.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

Review 10.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.